Specie	Nome del farmaco	ATC	Principio Attivo	Produttore
	Eryseng Parvo / 2 / 3 / 4	QI09AL01	porcine parvovirus, strain NADL-2 and Erysipelothrix rhusiopathiae, strain R32E11 (inactivated)	Laboratorios HIPRA, S.A.
	Eurican Herpes 205 / 2 / 3 / 4	QI07AA	Canine herpesvirus (F205 strain) antigens	Merial
	Equilis Prequenza Te / 2 / 3 / 4	QI05AL01	equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93, tetanus toxoid	Intervet International BV
	Equilis Prequenza / 2 / 3 / 4	QI05AA01	equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93	Intervet International BV
	Econor / 2 / 3 / 4	QJ01XQ02	valnemulin	Elanco Europe Ltd.
	Equilis West Nile / 2 / 3 / 4	QI05AA10	inactivated chimaeric flavivirus strain YF-WN	Intervet International BV
	Equisolon / 2 / 3 / 4	QH02AB06	Prednisolone	LE VET B.V.
	Equilis StrepE / 2 / 3 / 4	QI05AE	live deletion-mutant Streptococcus equi strain TW928	Intervet International BV
	Emdocam / 2 / 3 / 4	QM01AC06	meloxicam	Emdoka bvba
	Easotic / 2 / 3 / 4	QS02CA03	hydrocortisone aceponate /miconazole nitrate / gentamicin sulphate	Virbac
	Equip WNV (Duvaxyn WNV) / 2 / 3 / 4	QI05AA10	inactivated West Nile virus, strain VM-2	Zoetis Belgium SA
	Ecoporc Shiga / 2 / 3 / 4	QI09AB02	genetically modified recombinantShiga-toxin-2e antigen	IDT Biologika GmbH
	Equilis Te / 2 / 3 / 4	QI05AB03	tetanus toxoid	Intervet International BV
	Equioxx / 2 / 3 / 4	QM01AH90	firocoxib	Merial
	Eryseng / 2 / 3 / 4	QI09AB03	Erysipelothrix rhusiopathiae, strain R32E11 (inactivated)	Laboratorios HIPRA, S.A.
	Eravac / 2 / 3 / 4	QI08AA01	Inactivated rabbit haemorrhagic disease type 2 virus (RHDV2)	Laboratorios Hipra, S.A.
	Evalon / 2 / 3 / 4	QI01AN01	vaccine against coccidiosis in chickens	Laboratorios Hipra, S.A.